Cargando…
Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab
HS628 has been developed as a proposed biosimilar product of originator tocilizumab (Actemra®). An extensive physicochemical and biological characterization was conducted to assess similarity between HS628 and originator tocilizumab. The amino acid sequence was shown to be identical between HS628 an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352868/ https://www.ncbi.nlm.nih.gov/pubmed/28349061 http://dx.doi.org/10.1155/2017/4926168 |